FR2611501B1
(fr)
*
|
1987-03-04 |
1991-12-06 |
Corbiere Jerome |
Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
JP3382159B2
(ja)
*
|
1998-08-05 |
2003-03-04 |
株式会社東芝 |
情報記録媒体とその再生方法及び記録方法
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
FR2796551B1
(fr)
*
|
1999-07-23 |
2003-07-25 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
FR2796940B1
(fr)
*
|
1999-07-26 |
2005-04-08 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
AU2002230830A1
(en)
|
2000-11-03 |
2002-05-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
KR20100137023A
(ko)
|
2002-09-20 |
2010-12-29 |
안드렉스 랩스 엘엘씨 |
약제학적 정제
|
US20050163850A1
(en)
*
|
2003-10-31 |
2005-07-28 |
Wong Patrick S. |
Administration of levodopa and carbidopa
|
CN105152983A
(zh)
|
2007-01-29 |
2015-12-16 |
韩诺生物制药株式会社 |
N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
|
WO2009038396A2
(en)
*
|
2007-09-21 |
2009-03-26 |
Hanall Pharmaceutical Company. Ltd |
N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
|
MX2011000135A
(es)
|
2008-06-26 |
2011-02-25 |
Silanes Sa De Cv Lab |
Una nueva sal de glicinato de metformina para el control de la glucosa en sangre.
|
US20110021634A1
(en)
|
2009-06-18 |
2011-01-27 |
Patel Pranav Dushyant |
Processes for preparing metformin hydrochloride
|
WO2011049400A2
(ko)
*
|
2009-10-23 |
2011-04-28 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
|
CN101691344B
(zh)
*
|
2009-10-26 |
2012-10-17 |
漆又毛 |
一种二甲双胍酸式复盐化合物及制备方法
|
MX347372B
(es)
|
2010-05-26 |
2017-04-25 |
Vtv Therapeutics Llc |
Uso de metformina en combinacion con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa.
|
US8440723B2
(en)
*
|
2011-05-11 |
2013-05-14 |
Banavara L. Mylari |
Metformin salts of salicylic acid and its congeners
|
SG11201406987UA
(en)
|
2012-05-17 |
2014-12-30 |
Transtech Pharma Llc |
Glucokinase activator compositions for the treatment of diabetes
|
WO2018060959A1
(en)
|
2016-09-30 |
2018-04-05 |
Laboratorios Silanes S.A. De C.V. |
Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
|
WO2018060962A2
(en)
|
2016-09-30 |
2018-04-05 |
Laboratorios Silanes S.A. De C.V. |
Metformin amino acid compounds and methods of using the same
|
CN107118130A
(zh)
*
|
2017-05-11 |
2017-09-01 |
杜剑平 |
一类治疗肿瘤的药物化合物及其应用
|
AU2019287437A1
(en)
|
2018-06-12 |
2020-09-10 |
Vtv Therapeutics Llc |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
CN115073331A
(zh)
*
|
2021-03-15 |
2022-09-20 |
中国医学科学院药物研究所 |
二甲双胍肉桂酸盐一水合物及制备方法和其组合物与用途
|